Form 4 for VRDN Viridian Therapeutics, Inc.\DE
Accepted 2023-01-25 00:00:00 ET · period of report 2023-01-23 · accession 0000899243-23-002674 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-01-25 | 2023-01-23 | VRDN | Meisner Lara | GC, Sec | M - OptEx | $20.56 | +6,843 | 6,843 | New | +$140.7K |
| D | 2023-01-25 | 2023-01-23 | VRDN | Meisner Lara | GC, Sec | S - Sale+OE | $35.66 | -6,843 | 0 | -100% | -$244.0K |
| DM | 2023-01-25 | 2023-01-23 | VRDN | Meisner Lara | GC, Sec | M - OptEx | $0.00 | -6,843 | 39.8K | -15% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-01-23 | M | A | 4,971 | $23.03 | 4,971 | D | — | — | |
| 2 | Common | Common Stock | 2023-01-23 | S | D | 6,843 | $35.66 | 0 | D | — | — | (F1) This transaction was executed pursuant to a Rule 10b5-1 trading plan in multiple trades at prices ranging from $35.22 to $36.06. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 3 | Common | Common Stock | 2023-01-23 | M | A | 1,872 | $14.00 | 6,843 | D | — | — | |
| 4 | Derivative | Stock Option (Right to Buy) | 2023-01-23 | M | D | 1,872 | $0.00 | 20,003 | D | $14.00 · — to 2031-09-22 | 1,872 Common Stock | (F3) The option vested 25% on September 22, 2022 and then in equal monthly installments over the following 3 years, subject to the Reporting Person's continued service to Issuer through each vesting date. |
| 5 | Derivative | Stock Option (Right to Buy) | 2023-01-23 | M | D | 4,971 | $0.00 | 39,750 | D | $23.03 · — to 2031-01-18 | 4,971 Common Stock | (F2) The option vested 25% on December 2, 2021 and then in equal monthly installments over the following 3 years, subject to the Reporting Person's continued service to Issuer through each vesting date. |